bisphosphonates as antitumor agents in breast cancer
Published 12 years ago • 477 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
3:29
bisphosphonates may reduce breast cancer risk
-
3:43
do bisphosphonates reduce cancer risks?
-
3:07
breast cancer drug t-dm1 shows promise in trial
-
3:38
treating early breast cancer
-
4:19
asco: new treatment (t-dm1) for her2-positive advanced breast cancer?
-
6:44
new data and a review of bisphosphonate use in breast cancer
-
2:57
circulating tumor cells may identify asymptomatic late breast cancer recurrences
-
5:50
anastrozole and fulvestrant in hormone receptor-positive breast cancer
-
2:02
katherine trial: t-dm1 cuts her2-positve invasive breast cancer recurrence
-
2:07
triple-negative breast cancer and brca mutations
-
3:18
zoledronic acid fizzles for breast cancer
-
3:16
dual her2 blockade defers breast cancer in cleopatra
-
6:13
cleopatra: success with dual her2 blockade in breast cancer
-
5:50
anastrazole and fulvestrant in hormone receptor-positive breast cancer
-
2:56
everolimus in er-positive breast cancer
-
5:47
bone health and bisphosphonates in breast cancer: an overview
-
5:40
bone health and bisphosphonates in breast cancer: an overview
-
3:32
targeted therapies for triple-negative breast cancer
-
2:45
adjuvant zoledronic acid reduces breast cancer deaths